FRANCE – Sanofi has announced the acquisition of Origimm Biotechnology, an Austrian privately held biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing…
Read MoreTag: Translate Bio
Chinese tech giant Baidu licenses mRNA algorithm to Sanofi to optimize mRNA vaccines & therapy designs
CHINA – Chinese tech giant Baidu has announced an agreement with Sanofi, a leading biopharmaceutical company, to integrate LinearDesign, Baidu’s messenger ribonucleic acid (mRNA) design optimization platform, into Sanofi’s product…
Read MoreSanofi acquires USA biotech company Translate Bio in US$3.2 billion deal
FRANCE – Sanofi, a French multinational pharmaceutical company, has bought off USA based biotechnology company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after…
Read MoreSanofi plans to invest in ‘center of excellence’ that focuses on mRNA vaccines
FRANCE- The French pharmaceutical giant Sanofi has announced its plan to invest US$475.4m into a new facility focused on solely on the development and delivery of next-generation mRNA-based vaccines. The…
Read More